Rosi 10 mg (Dapagliflozin)
Dapagliflozin 10mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
MFDS item code 202004456 · Approved 2020.06.17
This product's status changed to Expired on 2025.06.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help patients with type 2 diabetes control their blood glucose levels. It can be prescribed alone when blood glucose control is difficult while concurrently following dietary and exercise regimens. Additionally, when combined with other diabetes medications, it can enhance blood glucose control effects. For example, it is used as an adjunct to medications like metformin, sulfonylureas, insulin, or sitagliptin when blood glucose control is insufficient. This medication is effective in improving blood glucose management when administered with various other drugs. Therefore, it is used for blood glucose control in type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used by patients with allergies to the active ingredients or excipients. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication either. Patients with hereditary lactose intolerance or certain deficiencies in lactose-decomposing enzymes should not be treated with this drug. Moreover, patients undergoing dialysis should not use this medication. Patients with low fluid volume or impaired kidney function should use this medication cautiously. This drug can lower blood pressure or affect kidney function, thus monitoring the patient's fluid status and kidney function is essential before and during administration. Especially, elderly patients or those on diuretics are at higher risk for hypotension and need careful observation. During treatment with this medication, genital infections and urinary tract infections may occur frequently. If any infection symptoms arise, immediate treatment should be sought, and discontinuation of the medication may be considered if the infection is severe. Hypoglycemic symptoms may appear, so dosage adjustments are necessary when used with insulin or sulfonylureas, which pose a hypoglycemic risk. Dehydration or hypotensive symptoms due to decreased fluid volume may occur, so patients at risk for dehydration should be vigilant about their hydration status. Diabetic ketoacidosis may develop, so if symptoms such as nausea, vomiting, abdominal pain, or difficulty in breathing appear, immediate consultation with a physician is required. This medication may impact kidney function; hence regular kidney function tests are necessary. Serious infections such as perineal necrosis may rarely occur, so if there is pain or redness around the genitals, medical advice should be sought immediately. Use of this medication during pregnancy is not recommended, and it should be discontinued upon confirmation of pregnancy. Lactating women are also recommended not to use this medication. The safety and efficacy of this medication in children have not been established, so it is not recommended for pediatric use. In cases of overdose, immediate medical attention should be obtained, and there is no information on whether this drug can be removed by dialysis. Caution is advised regarding hypoglycemic symptoms while driving or operating machinery during treatment with this medication. This medication should be stored in its original container, out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity; therefore, it must be stored in a tightly sealed container. The optimal storage temperature is at room temperature between 1°C and 30°C.
Yellow, bilaterally convex, diamond-shaped film-coated tablet
100 tablets/bottle, 8 tablets/box [(8 tablets/Alu-Alu)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin 10mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Dapagliflozin 5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharma Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
IYUN Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Litepharmtech Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.